The largest Bundibugyo virus outbreak on record has now produced confirmed imported cases in Europe, and American hospitals are receiving updated clinical guidance to prepare for the possibility that a case could reach the United States.
The European Centre for Disease Prevention and Control confirmed that as of July 1, 2026, two imported cases have been identified in Europe: one in France, and one involving a U.S. citizen who was medically evacuated to Germany for treatment. Both individuals were infected in the Democratic Republic of the Congo, where the outbreak has now reached 1,333 confirmed cases and 399 deaths in the DRC alone, according to the most recent data.
No Ebola cases have been confirmed in the United States as of this writing. The CDC assessed the risk to the American public as low. But the agency is not waiting for a domestic case to prepare its clinical network — and that preparation tells the story of how seriously federal health officials are treating this outbreak.
Why This Matters
This is not a distant outbreak that carries no domestic relevance. The Bundibugyo virus has now demonstrated it can reach France and Germany through ordinary international travel — countries with strong public health systems that, until these cases arrived, had no Ebola activity. The United States shares transatlantic air travel routes with all of those countries.
Bundibugyo virus carries a case fatality rate estimated between 25% and 50%, depending on the availability of supportive care. There is no approved vaccine or specific antiviral treatment for the Bundibugyo virus. The approved Ebola vaccine, Ervebo, was developed for the Zaire ebolavirus species; whether it offers meaningful cross-protection against Bundibugyo remains uncertain, and the WHO has determined the available evidence is insufficient to recommend its use in this outbreak.
That combination — high lethality, no approved treatment, no licensed vaccine — makes containment the only available defense. Containment depends on rapid clinical identification of potential cases, which is exactly what hospital readiness guidance is designed to support.
What We Know So Far
The outbreak was declared a WHO Public Health Emergency of International Concern on May 16, 2026 — the highest emergency designation available to the global health body.
Key facts as of July 1–2, 2026:
- 1,333 confirmed DRC cases and 399 total deaths (DRC data through June 29, 2026)
- 19 confirmed Uganda cases , including 2 deaths
- 1 confirmed France case — an imported case originating in DRC
- 1 U.S. citizen medically evacuated to Germany for treatment; case confirmed
- The outbreak originated in Ituri Province, northeastern DRC, and has spread to North Kivu Province and to Uganda's capital, Kampala
- The CDC issued a Health Alert Network advisory on May 16, 2026, formally alerting U.S. clinicians, public health practitioners, and laboratory staff
- U.S. entry restrictions have been in effect since May 18, 2026, limiting entry from DRC, Uganda, and South Sudan to U.S. citizens and nationals only
- Enhanced health screening is active at four U.S. airports — the specific airports are those receiving flights from DRC, Uganda, and South Sudan
The CDC's MMWR risk assessment, published June 5, 2026, assessed the likelihood of importation into the United States during a three-month window as very low— with the relative risk of importation to the U.S. compared to other locations estimated at 1.3%, based on international population movement modeling.
Where the Risk Is Highest
Within the United States, the facilities most likely to encounter a potential case are those in cities with direct or indirect international flight connections to DRC, Uganda, or neighboring countries. This includes major international airports in New York (JFK), Los Angeles (LAX), Chicago (ORD), Atlanta (ATL), Washington D.C. (IAD/DCA), Houston (IAH), and Miami (MIA).
Emergency departments and urgent care clinics in those metro areas — where returned travelers are most likely to first seek care — are the front line of any domestic detection effort. Clinicians in those facilities need to recognize that a patient who presents with fever, headache, muscle pain, vomiting, diarrhea, or unexplained bleeding and reports recent travel to or transit through DRC, Uganda, or South Sudan requires immediate isolation and notification of public health authorities.
What Doctors and Experts Say
"The situation in DRC and Uganda is serious and deserves serious, sustained attention," said the CDC's leadership in a June 5, 2026 press briefing. "Though the risk to the American public is low, we are prepared in the event there is a case of Ebola in the United States. CDC can confirm a diagnosis within hours, and our Laboratory Response Network extends that capacity to 41 states and local public health labs across the country."
CAPT. Satish K. Pillai, M.D., M.P.H., CDC's Incident Manager for the Ebola response, described this outbreak as "the largest Bundibugyo outbreak on record" and noted that early detection in DRC was complicated because transmission appeared to have been ongoing for some time before the outbreak was formally recognized in May 2026.
The ECDC assessed the likelihood of infection for people living in Europe and the United States as "very low," while emphasizing that close monitoring is ongoing and assessments will be updated as the situation evolves.
What the Evidence Shows — and What It Does Not
The CDC's risk assessment is formally current as of early June 2026 and will be updated as conditions change. The assessment explicitly states that the low overall risk to the American public is contingent on maintaining adequate public health resources to control the outbreak in DRC — the foundation on which that assessment rests.
The MMWR modeling published alongside the risk assessment describes scenarios in which a worsening outbreak trajectory in DRC could change the importation probability upward. Containing this outbreak at its source is the most effective protection for the United States and every other country.
The imported cases in France and Germany do not change the CDC's current risk designation, which anticipated the possibility of rare importations. Both cases were in individuals with direct DRC exposure, not evidence of community spread in Europe. But they are a real-world demonstration that the barrier between outbreak and importation is not absolute.
MedicalDaily Evidence Check
- Outbreak status : WHO PHEIC declared May 16, 2026
- Confirmed DRC cases : 1,333 (as of June 29, 2026)
- DRC deaths : 399
- Imported cases : France (1 confirmed), Germany (1 U.S. citizen in treatment)
- U.S. cases : None confirmed
- CDC risk assessment for U.S. : Low / very low importation probability
- Available treatment : Supportive care only; no approved vaccine or antiviral for Bundibugyo virus
- Key limitation : Risk assessment is modeling-based; real-world importation depends on outbreak trajectory in DRC
Who Faces the Greatest Risk?
For the American public, the risk categories are:
- Highest risk : Individuals who have traveled to Ituri Province, North Kivu Province, or other active transmission areas in DRC, or to Kampala, Uganda, in the past 21 days
- Elevated risk : Travelers to any part of DRC, Uganda, or South Sudan who had contact with sick individuals or attended funerals
- Healthcare workers : Clinicians who evaluate or treat a patient with symptoms consistent with Ebola disease without appropriate PPE, if that patient turns out to be infected
- General American public : Very low risk, particularly with current entry restrictions and airport screening in place
People who traveled to DRC, Uganda, or South Sudan recently and developed fever, fatigue, body aches, or unexplained bleeding should isolate themselves and call their local health department rather than walking into an emergency room without advance notice.
Symptoms and Warning Signs to Watch For
Bundibugyo virus disease typically begins with:
- Sudden onset of fever (often 101°F or higher)
- Severe headache
- Muscle pain and weakness
- Fatigue
- Sore throat
- Nausea, vomiting, or diarrhea
- Abdominal pain
In severe cases, symptoms progress to unexplained bleeding or bruising and can affect kidney and liver function. Symptoms typically appear 2 to 21 days after exposure, with most cases presenting within 6 to 12 days.
If you or someone you know has recently traveled to DRC, Uganda, or South Sudan and develops any of these symptoms, do not drive yourself to an emergency room. Call your local health department or 911 and inform them of your travel history before any clinical contact.
What You Can Do Now
- If you have recently traveled to DRC, Uganda, or South Sudan , monitor your health daily for 21 days. Your local health department will likely already be in contact with you if you passed through airport screening.
- Do not travel to Ituri, Nord-Kivu, or Sud-Kivu provinces in DRC. The CDC has issued a Level 3 Travel Health Notice — "Avoid Nonessential Travel" — for these areas.
- If you develop fever or other symptoms after recent travel , isolate yourself, call your local health department, and mention your travel history.
- Healthcare workers should review the CDC's updated Infection Prevention and Control guidance for U.S. hospitals evaluating potential viral hemorrhagic fever cases.
- If you are at an airport and feel ill after returning from an affected country, notify airport health staff immediately.
Cost and Access: What Patients Should Know
Ebola testing in the United States is currently performed at CDC's laboratory and at state public health laboratories participating in the Laboratory Response Network, which operates in 41 states. Testing is coordinated through public health authorities and does not require the patient to pay directly. If you are in self-monitoring following travel and need guidance, your local or state health department can provide a free consultation.
For individuals who need medical evacuation or intensive care, the National Ebola Training and Education Center coordinates with federally designated special pathogen treatment centers — facilities with enhanced biocontainment capabilities prepared to treat highly contagious, dangerous pathogens. These centers exist in multiple U.S. cities, including Atlanta, Omaha, Maryland, and Montana.
What Happens Next
The CDC's MMWR modeling analysis published June 5 indicated that without significant intensification of the containment response in DRC, outbreak trajectory projections could worsen. The WHO and CDC have both committed to continued and escalating resource deployment; the CDC has deployed more than 125 staff to DRC and Uganda and accessed $107 million in emergency response funding.
The entry restriction order from the United States was renewed on June 21, 2026, and is in effect for 30 days. It will need to be renewed again before July 21 if the outbreak continues. The ECDC updates its assessment weekly; MedicalDaily will report on any changes to CDC's domestic risk guidance.
The Bottom Line
The Bundibugyo Ebola outbreak in DRC is the largest in history for this virus species, has already produced imported cases in France and Germany, and has activated a U.S. hospital readiness response that clinicians across the country are receiving now. The risk to the average American is genuinely low, but low is not zero, and the absence of an approved vaccine or antiviral treatment makes early clinical recognition the most important defense the U.S. health system has. If you have recently traveled to affected areas, monitor your health and know how to report symptoms. If you have not, the practical action is to stay informed as this outbreak evolves.
